Diabetes Drug Ozempic Back in Supply in US After Shortage

Novo Nordisk's best-selling diabetes treatment drug Ozempic is back on the shelves in the United States after months of shortage.
Reuters Health Information

source https://www.medscape.com/viewarticle/989805?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost